Program at a Glance
Day 1 - March 28 (Thursday)
| Time | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
| 08:00-09:00 | Registration | |||
| 08:50-9:00 | Opening Remark | |||
| 9:00-10:15 | Joint Session 01 Asian Hematology Session I - EBV-associated lymphoid malignancy |
Education Session 01 Histiocytic neoplasm |
Scientific Session 01 Exploring the utilization of innovative technologies |
Scientific Session 02 The unmet needs in CML - Overcoming the obstacles of the road to cure |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Lecture 01 Somatic mutations and clonal dynamics in human blood cells |
|||
| 11:15-12:00 | Presidential Symposium 01 Lab-on-a-chip in hematology |
|||
| 12:00-12:15 | Break | |||
| 12:15-13:05 | Satellite Symposium 01 |
Satellite Symposium 02 |
Satellite Symposium 03 |
Satellite Symposium 04 |
| 13:05-13:50 | Poster Viewing 1 | |||
| 13:50-15:20 | Oral Presentation 01 Acute leukemia -1 |
Oral Presentation 02 Lymphoma |
Oral Presentation 03 Hematopoietic stem cell transplantation / Cellular therapy |
Oral Presentation 04 Laboratory hematology |
| 15:20-15:30 | Break | |||
| 15:30-16:45 | Joint Sesseion 02 EHA-KSH Joint Symposium - MM |
Scientific Session 03 Wise perspective on new approaches in hemophilia |
Scientific Session 04 For the next generation CAR-T cells |
Scientific Session 05 Deepened understanding of AML using multi-omics approaches |
| 16:45-16:55 | Break | |||
| 16:55-18:10 | Scientific Session 06 Insignts into lymphoma pathobiology |
Scientific Session 07 Profound understanding of diagnosis and therapy in MDS |
Scientific Session 08 Leukemogenesis in children and adults |
Education Session 02 Basics for trainees (Kor) |
| 18:10-18:30 | Break | |||
| 18:30-20:00 | Welcome Reception (Aston House) | |||
Day 2 - March 29 (Friday)
| Time | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
| 9:00-10:15 | Joint Session 03 ASH-KSH Joint Symposium - Ped-ALL |
Education Session 03 Leaps and hurdles in transfusion medicine (Kor) |
Scientific Session 09 Clonal hematopoiesis: What should we know? |
Scientific Session 10 Predictive biomarkers in multiple myeloma |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Lecture 02 How to win: Competitive strategies in the hematopoietic stem cell niche |
|||
| 11:15-12:00 | Poster Viewing 2 | |||
| 12:00-12:15 | Break | |||
| 12:15-13:05 | Satellite Symposium 05 |
Satellite Symposium 06 |
Satellite Symposium 07 |
Satellite Symposium 08 |
| 13:05-13:20 | Break | |||
| 13:20-14:50 | Oral Presentation 05 Acute leukemia -2 |
Oral Presentation 06 Multiple myeloma |
Oral Presentation 07 Myeloid neoplasm & Bone marrow failure |
Oral Presentation 08 Thrombocytopenia & Supportive care |
| 14:50-15:05 | Break | |||
| 15:05-16:20 | Joint Session 04 Current interests in hematologic disease in Asia |
Scientific Session 11 Quality-of-life revisited |
Scientific Session 12 Novel approaches for diagnosis & treatment of acute lymphoblastic leukemia |
Education Session 04 Monoclonal gammopathies of clinical significance |
| 16:20-16:35 | Break | |||
| 16:35-17:50 | Scientific Session 13 Advancing in knowledge of rare hematologic disorders |
Joint Session 05 Asian Hematology Session II - AML |
Education Session 05 Principles of anticoagulation - All about blood clots (Kor) |
|
| 17:50-18:30 | Cocktail Reception (Vista Lobby) | |||
| 18:30-20:30 | Gala Dinner (Vista Hall) | |||
Day 3 - March 30 (Saturday)
| Time | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
| 07:30-08:30 | Business Meeting |
|||
| 08:30-9:00 | Young Investigator Award Presentation |
|||
| 9:00-10:15 | Education Session 06 Essential knowledge for optimal hematologic consultation (Kor) |
Scientific Session 14 Novel insights into pathogenesis of MPN |
Scientific Session 15 Immunotherapies for lymphomas non-benefited from CAR-T cell therapy |
Education Session 07 Basic genomics for clinical hematologists (Kor) |
| 10:15-10:30 | Break | |||
| 10:30-11:15 | Plenary Abstract Presentation 01 | |||
| 11:15-11:45 | Award Ceremony & Closing | |||
- Hosted by
-
- Supported by
-
